Pasar al contenido principal

RED ESPAÑOLA DE ADENOVIRUS: DESDE LA BIOLOGIA BASICA A LA NANOBIOMEDICINA

RED2022-134221-T

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Redes Investigación /Redes Excelencia
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Position-specific polymeric-coated oncolytic adenovirus improves anti-tumor efficacy and evades neutralizing antibodies in pancreatic cancer models

  • Otero, Marc
  • Estrany Castillo, Francesc
  • Pembaur, Daniel
  • Gracia Batllori, Albert
  • Parés, Marta
  • Díaz Permanyer, Adrià
  • Brugada-Vilà, Pau
  • Fornaguera, Cristina
  • Cascante, Anna
  • Borrós, Salvador
  • Kreppel, Florian
  • Fillat, Cristina
Enhancing the safety and efficacy of systemically administered oncolytic adenoviruses remains a significant challenge to achieve effective targeting of primary tumors and disseminated disease. Intravenous administration exposes viral particles to various blood components interfering with their therapeutic activity. To protect adenoviruses from the inactivating factors we developed a shielding strategy based on a nanoparticle formulation reactive to a specific-site in the hexon hypervariable region 1. We propose a novel coating approach based on the combination of a bioresponsive oligopeptide-modified poly(β-aminoester)s (OM-PBAE-CRRR) and an irreversible linear PEG polymer with protruding ends to shield the oncolytic adenovirus AdNuPARc-E (PEPB). The formulated virus displays a slight delay in the transduction and replicative capacity at early time points that normalizes in a few days. Interestingly, similar oncolytic efficacy to the naked virus was observed in vitro, with enhanced antitumor effect in vivo in a pancreatic cancer model. In accordance, PEPB showed significantly enhanced pharmacokinetics and increased liver and tumor transduction in the xenograft model. In the presence of neutralizing antibodies (NAbs) coated viral particles maintained the infectivity and the replication capacity. Notably, in pre-immunized immunocompetent mice, protection from NAbs resulted in a higher viral accumulation in tumors than in the liver and was associated with significant antitumor activity. In summary, our findings indicate that the proposed formulation PEPB —the oncolytic adenovirus AdNuPARc-E site-specifically shielded with OM-PBAE-CRRR/PEG — offers a promising approach to improve tumor targeting after systemic administration, even in the presence of pre-existing neutralizing antibodies., info:eu-repo/semantics/publishedVersion
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Physical Virology in Spain

  • Reguera, David
  • Pablo, Pedro J. de
  • Abrescia, Nicola G. A.
  • Mateu, Mauricio G.
  • Hernández-Rojas, Javier
  • Castón, José R.
  • San Martín, Carmen
Virus particles consist of a protein coat that protects their genetic material and delivers it to the host cell for self-replication. Understanding the interplay between virus structure and function is a requirement for understanding critical processes in the infectious cycle such as entry, uncoating, genome metabolism, capsid assembly, maturation, and propagation. Together with well-established techniques in cell and molecular biology, physical virology has emerged as a rapidly developing field, providing detailed, novel information on the basic principles of virus assembly, disassembly, and dynamics. The Spanish research community contains a good number of groups that apply their knowledge on biology, physics, or chemistry to the study of viruses. Some of these groups got together in 2010 under the umbrella of the Spanish Interdisciplinary Network on Virus Biophysics (BioFiViNet). Thirteen years later, the network remains a fertile ground for interdisciplinary collaborations geared to reveal new aspects on the physical properties of virus particles, their role in regulating the infectious cycle, and their exploitation for the development of virus-based nanotechnology tools. Here, we highlight some achievements of Spanish groups in the field of physical virology., The authors acknowledge funding by grants from the Spanish Ministry of Economy, Industry and Competitiveness (FIS2017-89549-R, MDM-2014-0377, and FIS2017-90701-REDT); the Human Frontiers Science Program (HFSPO RGP0012/2018); the Spanish State Research Agency (AEI/10.13039/501100011033); the European Regional Development Fund (PID2019-104098GB-I00, PID2019-105225GB-I00, RTI2018-096635-B-I00, PID2021-126130OB-100, PID2021-126570NB-I00, PID2021-126608OB-I00, and PID2021-126973OB-I00); the Spanish State Research Agency (CEX2021-00154-S, CEX2021-001136-S, PID2020-113287RB-I00, PID2022-136456NB-I00, RED2022-134221-T, and RED2022-134654-T); CSIC (2023AEP082 and 202120E47, LifeHub); and the Comunidad Autónoma de Madrid (P2018/NMT-4389)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-00154-S) and (CEX2021-001136-S)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Position-specific polymeric-coated oncolytic adenovirus improves anti-tumor efficacy and evades neutralizing antibodies in pancreatic cancer models

  • Otero, Marc
  • Estrany Castillo, Francesc
  • Pembaur, Daniel
  • Gracia Batllori, Albert
  • Parés, Marta
  • Díaz Permanyer, Adrià
  • Brugada-Vilà, Pau
  • Fornaguera, Cristina
  • Cascante, Anna
  • Borrós, Salvador
  • Kreppel, Florian
  • Fillat, Cristina
Enhancing the safety and efficacy of systemically administered oncolytic adenoviruses remains a significant challenge to achieve effective targeting of primary tumors and disseminated disease. Intravenous administration exposes viral particles to various blood components interfering with their therapeutic activity. To protect adenoviruses from the inactivating factors we developed a shielding strategy based on a nanoparticle formulation reactive to a specific-site in the hexon hypervariable region 1. We propose a novel coating approach based on the combination of a bioresponsive oligopeptide-modified poly(β-aminoester)s (OM-PBAE-CRRR) and an irreversible linear PEG polymer with protruding ends to shield the oncolytic adenovirus AdNuPARc-E (PEPB). The formulated virus displays a slight delay in the transduction and replicative capacity at early time points that normalizes in a few days. Interestingly, similar oncolytic efficacy to the naked virus was observed in vitro, with enhanced antitumor effect in vivo in a pancreatic cancer model. In accordance, PEPB showed significantly enhanced pharmacokinetics and increased liver and tumor transduction in the xenograft model. In the presence of neutralizing antibodies (NAbs) coated viral particles maintained the infectivity and the replication capacity. Notably, in pre-immunized immunocompetent mice, protection from NAbs resulted in a higher viral accumulation in tumors than in the liver and was associated with significant antitumor activity. In summary, our findings indicate that the proposed formulation PEPB —the oncolytic adenovirus AdNuPARc-E site-specifically shielded with OM-PBAE-CRRR/PEG — offers a promising approach to improve tumor targeting after systemic administration, even in the presence of pre-existing neutralizing antibodies., info:eu-repo/semantics/publishedVersion